Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2/3 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pain, Postoperative 17Breast Neoplasms 12Brain Neoplasms 11Agnosia 7Neoplasms 6Lung Neoplasms 5Delirium 5Thyroid Neoplasms 4Stomach Neoplasms 4Pituitary Neoplasms 3Pain 3Emergence Delirium 3Colorectal Neoplasms 3Chronic Pain 3Supratentorial Neoplasms 2Rectal Neoplasms 2Prostatic Neoplasms 2Pheochromocytoma 2Pain, Intractable 2Neoplasm Metastasis 2Liver Neoplasms 2Inflammation 2Dexmedetomidine 2Colonic Neoplasms 2Central Nervous System Diseases 2Abdominal Neoplasms 2Urinary Bladder Neoplasms 1Spinal Cord Neoplasms 1Sleep Initiation and Maintenance Disorders 1Sleep Deprivation 1

Interventions

Exercise 5Vitamin D 3Resistance Training 3Ascorbic Acid 3salicylsalicylic acid 2palbociclib 2epigallocatechin gallate 2Tea 2Tablets 2Surgical Procedures, Operative 2Sufentanil 2Spironolactone 2Oxycodone 2Omeprazole 2Nutrition Assessment 2Morphine 2Metformin 2Ketorolac 2Infliximab 2Ibuprofen 2Fish Oils 2Endurance Training 2Dexmedetomidine 2Blood Specimen Collection 2Aspirin 2ziprasidone 1soybean oil, phospholipid emulsion 1semaglutide 1montelukast 1microcrystalline cellulose 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Inflammation × Dexmedetomidine × Clear all
NCT05742438 2025-04-02

Effects of Dexmedetomidine/Lidocaine/Intrathecal Morphine on Cancer Metastasis Biomarker After Colorectal Surgery

Samsung Medical Center

Phase NA Completed
114 enrolled
Gastrointestinal

Inflammation, Neoplasm Metastasis, Colorectal Neoplasms

NCT04106999 2022-11-03

Dexmedetomidine and HIPEC

University of British Columbia

Phase 2/3 Unknown
20 enrolled

Inflammation, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡